These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15173479)

  • 1. Timing of initial surfactant treatment for infants 23 to 29 weeks' gestation: is routine practice evidence based?
    Horbar JD; Carpenter JH; Buzas J; Soll RF; Suresh G; Bracken MB; Leviton LC; Plsek PE; Sinclair JC;
    Pediatrics; 2004 Jun; 113(6):1593-602. PubMed ID: 15173479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two strategies for surfactant prophylaxis in very premature infants: a multicenter randomized trial.
    Kendig JW; Ryan RM; Sinkin RA; Maniscalco WM; Notter RH; Guillet R; Cox C; Dweck HS; Horgan MJ; Reubens LJ; Risemberg H; Phelps DL
    Pediatrics; 1998 Jun; 101(6):1006-12. PubMed ID: 9606227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeat surfactant therapy for postsurfactant slump.
    Katz LA; Klein JM
    J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective surfactant prophylaxis in preterm infants born at < or =31 weeks' gestation using the stable microbubble test in gastric aspirates.
    Fiori HH; Fritscher CC; Fiori RM
    J Perinat Med; 2006; 34(1):66-70. PubMed ID: 16489887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation.
    Kattwinkel J; Bloom BT; Delmore P; Davis CL; Farrell E; Friss H; Jung AL; King K; Mueller D
    Pediatrics; 1993 Jul; 92(1):90-8. PubMed ID: 8516091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic versus Early Rescue Surfactant Treatment in Preterm Infants Born at Less than 30 Weeks Gestation or with Birth Weight Less than or Equal 1,250 Grams.
    Chun J; Sung SI; Ho YH; Kim J; Park GY; Yoon SA; Ahn SY; Chang YS; Park WS
    J Korean Med Sci; 2017 Aug; 32(8):1288-1294. PubMed ID: 28665065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for early death among extremely low-birth-weight infants.
    Shankaran S; Fanaroff AA; Wright LL; Stevenson DK; Donovan EF; Ehrenkranz RA; Langer JC; Korones SB; Stoll BJ; Tyson JE; Bauer CR; Lemons JA; Oh W; Papile LA
    Am J Obstet Gynecol; 2002 Apr; 186(4):796-802. PubMed ID: 11967510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation.
    Kendig JW; Notter RH; Cox C; Reubens LJ; Davis JM; Maniscalco WM; Sinkin RA; Bartoletti A; Dweck HS; Horgan MJ
    N Engl J Med; 1991 Mar; 324(13):865-71. PubMed ID: 2000109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
    Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
    Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome.
    Soll R; Ozek E
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000141. PubMed ID: 19160177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
    de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
    Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tidal volume delivery during surfactant administration in the delivery room.
    Schmölzer GM; Kamlin CO; Dawson JA; Morley CJ; Davis PG
    Intensive Care Med; 2011 Nov; 37(11):1833-9. PubMed ID: 21976187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome.
    Bloom BT; Kattwinkel J; Hall RT; Delmore PM; Egan EA; Trout JR; Malloy MH; Brown DR; Holzman IR; Coghill CH; Carlo WA; Pramanik AK; McCaffree MA; Toubas PL; Laudert S; Gratny LL; Weatherstone KB; Seguin JH; Willett LD; Gutcher GR; Mueller DH; Topper WH
    Pediatrics; 1997 Jul; 100(1):31-8. PubMed ID: 9200357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of surfactant for prevention of respiratory distress syndrome in newborn infants in spontaneous breathing. A randomized multicentre clinical pilot-study.
    Dambeanu JM; Parmigiani S; Marinescu B; Bevilacqua G
    Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():39-45. PubMed ID: 10021716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prenatal corticosteroid and early surfactant therapy in infants born at < or = 30 weeks gestation].
    Valls i Soler A; Páramo Andrés S; Fernández-Ruanova B;
    An Pediatr (Barc); 2004 Aug; 61(2):118-23. PubMed ID: 15274875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early administration of the second surfactant dose in preterm infants with severe respiratory distress syndrome.
    Köksal N; Akpinar R; Cetinkaya M
    Turk J Pediatr; 2009; 51(6):556-64. PubMed ID: 20196389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early versus late surfactant treatment in preterm infants of 27 to 32 weeks' gestational age: a multicenter controlled clinical trial.
    Gortner L; Wauer RR; Hammer H; Stock GJ; Heitmann F; Reiter HL; Kühl PG; Möller JC; Friedrich HJ; Reiss I; Hentschel R; Jorch G; Hieronimi G; Kuhls E
    Pediatrics; 1998 Nov; 102(5):1153-60. PubMed ID: 9794948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.